Regulation of mark-up on medicine prices in Zimbabwe: a pilot survey from 92 community pharmacies in the metropolitan area of Harare
- PMID: 39546124
- PMCID: PMC11566648
- DOI: 10.1186/s13561-024-00574-8
Regulation of mark-up on medicine prices in Zimbabwe: a pilot survey from 92 community pharmacies in the metropolitan area of Harare
Abstract
Background: Medicine pricing in the community pharmacy sector in Zimbabwe significantly influences accessibility to health care. In this pilot survey, we investigated how community pharmacies in Zimbabwe apply various mark-up strategies to essential and non-essential medicines, and gathered community pharmacists' perspectives on mark-up regulation.
Methods: Using an adapted methodology endorsed by the World Health Organization and Health Action International for studying medicine prices and availability, we conducted a quantitative cross-sectional pilot survey for 46 medicines (31 essential and 15 non-essential) identified using the Zimbabwe Essential Medicines List and classified according to the Vital, Essential, and Non-essential (VEN) tool. We conducted the pilot survey in 92 community pharmacies in the metropolitan area of Harare, Zimbabwe.
Results: We gathered a total of 92 responses from 167 distributed questionnaires. The most prevalent mark-up strategy was the cost-plus fixed percentage.The median mark-up for all medicines in the community pharmacies was 60% (interquartile range 50- 82%). We found a statistically significant difference in the median mark-up by essentiality of medicines (p < 0.001), essential medicines had a median mark-up price of 62% while non-essential medicines had a mark-up of 56%. Antipsychotics had the highest mark-up at 82%, while anti-neoplastic medicine had the lowest at 36%. Overall, 55% of the community pharmacists did not support mark-up regulation.
Conclusion: Mark-up strategies varied across community pharmacies in the metropolitan area of Harare. Without mark-up regulation, essential medicines remain significantly expensive in Zimbabwe. We recommend mark-up regulation in Zimbabwe's community pharmacy sector and emphasize the effective use of multiple pricing strategies to reduce medicine prices. .
Keywords: Affordability; Essential medicine; Mark-up; Pricing regulation.
© 2024. The Author(s).
Conflict of interest statement
Similar articles
-
Price, Availability, and Affordability of Antineoplastic Medicines in Harare's Public and Private Institutions: Implication for Access.Value Health Reg Issues. 2021 Sep;25:118-125. doi: 10.1016/j.vhri.2020.12.013. Epub 2021 May 6. Value Health Reg Issues. 2021. PMID: 33965656
-
Evaluation of prices, availability and affordability of essential medicines in Lahore Division, Pakistan: A cross-sectional survey using WHO/HAI methodology.PLoS One. 2019 Apr 25;14(4):e0216122. doi: 10.1371/journal.pone.0216122. eCollection 2019. PLoS One. 2019. PMID: 31022276 Free PMC article.
-
Evaluation of availability, price, and affordability of cardiovascular, diabetes, and global medicines in Abuja, Nigeria.PLoS One. 2021 Aug 12;16(8):e0255567. doi: 10.1371/journal.pone.0255567. eCollection 2021. PLoS One. 2021. PMID: 34383799 Free PMC article.
-
The prices people pay for medicines in Zimbabwe.Cent Afr J Med. 2009 Jan-Apr;55(1-4):14-9. doi: 10.4314/cajm.v55i1-4.63635. Cent Afr J Med. 2009. PMID: 21977842
-
Implementation of medicines pricing policies in sub-Saharan Africa: systematic review.Syst Rev. 2022 Dec 1;11(1):257. doi: 10.1186/s13643-022-02114-z. Syst Rev. 2022. PMID: 36457058 Free PMC article.
References
-
- Morgan SG, Bathula HS, Moon S. Pricing of pharmaceuticals is becoming a major challenge for health systems. BMJ. 2020;368:l4627. - PubMed
-
- WHO. SDG, Target. 3.8 | Achieve universal health coverage, including financial risk protection, access to quality essential health-care services and access to safe, effective, quality and affordable essential medicines and vaccines for all 2016 [ https://www.who.int/data/gho/data/themes/topics/indicator-groups/indicat...
-
- Ondo Z. Regulatory Analysis of Mark-up structure in Medicine prices by the Pharmaceutical Industry in South Africa. J Pharm Care Health Syst. 2019;6(2).
-
- Mutyavaviri SN, Mensah KB, Marume A, Boamah Mensah AB, Bangalee V. Price, availability, and affordability of Antineoplastic Medicines in Harare’s public and private institutions: implication for Access. Value Health Reg Issues. 2021;25:118–25. - PubMed
-
- Marume A, Nyandoro G, Mutingwende I, Murambinda P, Bangalee V. Price and availability survey of essential medicines in the Harare province, Zimbabwe. Cent Afr J Med. 2018;63:7–8.
LinkOut - more resources
Full Text Sources